Natalie J. Galant

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis

Nowell M. Fine, Margot K. Davis, Kim Anderson et al. · Canadian Journal of Cardiology · 2020 · 111 citations

Medicine, Cardiology, Internal Medicine +11

Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin

Jeffrey N. Higaki, Avijit Chakrabartty, Natalie J. Galant et al. · Amyloid · 2016 · 88 citations · Full text

Pharmacy, Immunology, Pathology +17

MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes

Shawn Veitch, Makon‐Sébastien Njock, Mark Chandy et al. · Cardiovascular Diabetology · 2022 · 80 citations · Full text

Medicine, Biomedical Sciences, Cardiology +17

Physiologically Important Electrolytes as Regulators of TDP-43 Aggregation and Droplet-Phase Behavior

Yulong Sun, Alison Medina Cruz, Kevin C. Hadley et al. · Biochemistry · 2018 · 39 citations

Life Sciences, Biochemistry, Neuroscience +17

Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses

Natalie J. Galant, Antoinette Bugyei‐Twum, Rishi Rakhit et al. · Scientific Reports · 2016 · 38 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +17